Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus

Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials

(2020) Fabio Marsico et al.   EUROPEAN HEART JOURNAL

Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease

(2020) Valentina Guarnotta et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

Adipokines and Myokines: A Pivotal Role in Metabolic and Cardiovascular Disorders

(2018) Hye Soo Chung et al.   CURRENT MEDICINAL CHEMISTRY

Physiology and role of irisin in glucose homeostasis

(2017) Nikolaos Perakakis et al.   Nature Reviews Endocrinology

Glucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes

(2017) Giovanna Muscogiuri et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

From C-Reactive Protein to Interleukin-6 to Interleukin-1

(2016) Paul M Ridker   CIRCULATION RESEARCH

Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes

(2016) Jia Liu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Sarcopenia and sarcopenic obesity

(2016) Kyung Mook Choi   KOREAN JOURNAL OF INTERNAL MEDICINE

Circulating Irisin Concentrations Are Associated with a Favourable Lipid Profile in the General Population

(2016) Simon Oelmann et al.   PLoS One

Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes

(2015) T.-Y. Liu et al.   CLINICAL SCIENCE

The Implications of Sarcopenia and Sarcopenic Obesity on Cardiometabolic Disease

(2015) Tae Nyun Kim et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Irisin and Its Relation to Insulin Resistance and Puberty in Obese Children: A Longitudinal Analysis

(2015) Thomas Reinehr et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Irisin: a new molecular marker and target in metabolic disorder

(2015) Jia-qi Chen et al.   Lipids in Health and Disease

Lower irisin level in patients with type 2 diabetes mellitus: A case-control study and meta-analysis

(2015) Chun Zhang et al.   Journal of Diabetes

Irisin and FGF21 Are Cold-Induced Endocrine Activators of Brown Fat Function in Humans

(2014) Paul Lee et al.   Cell Metabolism

Impact of Visceral Fat on Skeletal Muscle Mass and Vice Versa in a Prospective Cohort Study: The Korean Sarcopenic Obesity Study (KSOS)

(2014) Tae Nyun Kim et al.   PLoS One

Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: Cardiovascular Health Study

(2013) David M. Tehrani et al.   ATHEROSCLEROSIS

RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation

(2013) Peng Yi et al.   CELL

Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study

(2013) G. Lowe et al.   DIABETES

Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling

(2013) Y. Zhang et al.   DIABETES

Serum irisin levels in new-onset type 2 diabetes

(2013) Yeon-Kyung Choi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome

(2013) Kyung Hee Park et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lower circulating irisin is associated with type 2 diabetes mellitus

(2013) Jian-Jun Liu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Exendin-4 inhibits iNOS expression at the protein level in LPS-stimulated Raw264.7 macrophage by the activation of cAMP/PKA pathway

(2012) Seo-Yoon Chang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Inflammatory Mechanisms in Obesity

(2011) Margaret F. Gregor et al.   Annual Review of Immunology

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk

(2010) M. C. Amato et al.   DIABETES CARE

Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)

(2008) Aramesh Saremi et al.   ATHEROSCLEROSIS

Sarcopenic obesity: A new category of obesity in the elderly

(2008) Mauro Zamboni et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES